Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.

Market Analysis and Insights: Global Skin Disease Treatment Market

The global Skin Disease Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

There are many causes of skin diseases. For example, skin diseases caused by infectious factors, such as leprosy, scabies, fungal diseases, and skin bacterial infections, are often infectious, which not only affects physical health but also causes panic and social discrimination. With the improvement of living standards and the advancement of science and technology, infectious diseases such as leprosy have been significantly controlled worldwide.

Report Covers:

This report presents an overview of global market for Skin Disease Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Skin Disease Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Skin Disease Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Skin Disease Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Skin Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Skin Disease Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Skin Disease Treatment Market Report

Report Metric	Details
Report Name	Skin Disease Treatment Market
Segment by Type	Medicated Creams and Ointments Antibiotics Vitamins and Steroids Antihistamines Laser Therapy Antifungals Others
Segment by Application	Dermatology Clinics Skincare Clinics Hospitals Aesthetic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	APEIRON Biologics AG, HanAll BioPharma, GlaxoSmithKline plc., Allergen, Plc., Anacor Pharmaceuticals, Celgene, Basilea Pharmaceutica, Cipher Pharmaceuticals, Agenus, Astion Pharma A/S, Bristol-Myers Squibb, Almirall S.A., Galderma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Skin Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Disease Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Disease Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Skin Disease Treatment Market report?

Ans: The main players in the Skin Disease Treatment Market are APEIRON Biologics AG, HanAll BioPharma, GlaxoSmithKline plc., Allergen, Plc., Anacor Pharmaceuticals, Celgene, Basilea Pharmaceutica, Cipher Pharmaceuticals, Agenus, Astion Pharma A/S, Bristol-Myers Squibb, Almirall S.A., Galderma

What are the Application segmentation covered in the Skin Disease Treatment Market report?

Ans: The Applications covered in the Skin Disease Treatment Market report are Dermatology Clinics, Skincare Clinics, Hospitals, Aesthetic Centers, Others

What are the Type segmentation covered in the Skin Disease Treatment Market report?

Ans: The Types covered in the Skin Disease Treatment Market report are Medicated Creams and Ointments, Antibiotics, Vitamins and Steroids, Antihistamines, Laser Therapy, Antifungals, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Skin Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Medicated Creams and Ointments

1.2.3 Antibiotics

1.2.4 Vitamins and Steroids

1.2.5 Antihistamines

1.2.6 Laser Therapy

1.2.7 Antifungals

1.2.8 Others

1.3 Market by Application

1.3.1 Global Skin Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Dermatology Clinics

1.3.3 Skincare Clinics

1.3.4 Hospitals

1.3.5 Aesthetic Centers

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Skin Disease Treatment Market Perspective (2019-2030)

2.2 Global Skin Disease Treatment Growth Trends by Region

2.2.1 Skin Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Skin Disease Treatment Historic Market Size by Region (2019-2024)

2.2.3 Skin Disease Treatment Forecasted Market Size by Region (2025-2030)

2.3 Skin Disease Treatment Market Dynamics

2.3.1 Skin Disease Treatment Industry Trends

2.3.2 Skin Disease Treatment Market Drivers

2.3.3 Skin Disease Treatment Market Challenges

2.3.4 Skin Disease Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Skin Disease Treatment by Players

3.1.1 Global Skin Disease Treatment Revenue by Players (2019-2024)

3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Skin Disease Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Skin Disease Treatment Market Concentration Ratio

3.4.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2023

3.5 Global Key Players of Skin Disease Treatment Head office and Area Served

3.6 Global Key Players of Skin Disease Treatment, Product and Application

3.7 Global Key Players of Skin Disease Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Disease Treatment Breakdown Data by Type

4.1 Global Skin Disease Treatment Historic Market Size by Type (2019-2024)

4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2025-2030)

5 Skin Disease Treatment Breakdown Data by Application

5.1 Global Skin Disease Treatment Historic Market Size by Application (2019-2024)

5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Skin Disease Treatment Market Size (2019-2030)

6.2 North America Skin Disease Treatment Market Size by Type

6.2.1 North America Skin Disease Treatment Market Size by Type (2019-2024)

6.2.2 North America Skin Disease Treatment Market Size by Type (2025-2030)

6.2.3 North America Skin Disease Treatment Market Share by Type (2019-2030)

6.3 North America Skin Disease Treatment Market Size by Application

6.3.1 North America Skin Disease Treatment Market Size by Application (2019-2024)

6.3.2 North America Skin Disease Treatment Market Size by Application (2025-2030)

6.3.3 North America Skin Disease Treatment Market Share by Application (2019-2030)

6.4 North America Skin Disease Treatment Market Size by Country

6.4.1 North America Skin Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Skin Disease Treatment Market Size by Country (2019-2024)

6.4.3 North America Skin Disease Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Skin Disease Treatment Market Size (2019-2030)

7.2 Europe Skin Disease Treatment Market Size by Type

7.2.1 Europe Skin Disease Treatment Market Size by Type (2019-2024)

7.2.2 Europe Skin Disease Treatment Market Size by Type (2025-2030)

7.2.3 Europe Skin Disease Treatment Market Share by Type (2019-2030)

7.3 Europe Skin Disease Treatment Market Size by Application

7.3.1 Europe Skin Disease Treatment Market Size by Application (2019-2024)

7.3.2 Europe Skin Disease Treatment Market Size by Application (2025-2030)

7.3.3 Europe Skin Disease Treatment Market Share by Application (2019-2030)

7.4 Europe Skin Disease Treatment Market Size by Country

7.4.1 Europe Skin Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Skin Disease Treatment Market Size by Country (2019-2024)

7.4.3 Europe Skin Disease Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Skin Disease Treatment Market Size (2019-2030)

8.2 China Skin Disease Treatment Market Size by Type

8.2.1 China Skin Disease Treatment Market Size by Type (2019-2024)

8.2.2 China Skin Disease Treatment Market Size by Type (2025-2030)

8.2.3 China Skin Disease Treatment Market Share by Type (2019-2030)

8.3 China Skin Disease Treatment Market Size by Application

8.3.1 China Skin Disease Treatment Market Size by Application (2019-2024)

8.3.2 China Skin Disease Treatment Market Size by Application (2025-2030)

8.3.3 China Skin Disease Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Skin Disease Treatment Market Size (2019-2030)

9.2 Asia Skin Disease Treatment Market Size by Type

9.2.1 Asia Skin Disease Treatment Market Size by Type (2019-2024)

9.2.2 Asia Skin Disease Treatment Market Size by Type (2025-2030)

9.2.3 Asia Skin Disease Treatment Market Share by Type (2019-2030)

9.3 Asia Skin Disease Treatment Market Size by Application

9.3.1 Asia Skin Disease Treatment Market Size by Application (2019-2024)

9.3.2 Asia Skin Disease Treatment Market Size by Application (2025-2030)

9.3.3 Asia Skin Disease Treatment Market Share by Application (2019-2030)

9.4 Asia Skin Disease Treatment Market Size by Region

9.4.1 Asia Skin Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Skin Disease Treatment Market Size by Region (2019-2024)

9.4.3 Asia Skin Disease Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Skin Disease Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Skin Disease Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Skin Disease Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 APEIRON Biologics AG

11.1.1 APEIRON Biologics AG Company Details

11.1.2 APEIRON Biologics AG Business Overview

11.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction

11.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2019-2024)

11.1.5 APEIRON Biologics AG Recent Developments

11.2 HanAll BioPharma

11.2.1 HanAll BioPharma Company Details

11.2.2 HanAll BioPharma Business Overview

11.2.3 HanAll BioPharma Skin Disease Treatment Introduction

11.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2019-2024)

11.2.5 HanAll BioPharma Recent Developments

11.3 GlaxoSmithKline plc.

11.3.1 GlaxoSmithKline plc. Company Details

11.3.2 GlaxoSmithKline plc. Business Overview

11.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction

11.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2019-2024)

11.3.5 GlaxoSmithKline plc. Recent Developments

11.4 Allergen, Plc.

11.4.1 Allergen, Plc. Company Details

11.4.2 Allergen, Plc. Business Overview

11.4.3 Allergen, Plc. Skin Disease Treatment Introduction

11.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2019-2024)

11.4.5 Allergen, Plc. Recent Developments

11.5 Anacor Pharmaceuticals

11.5.1 Anacor Pharmaceuticals Company Details

11.5.2 Anacor Pharmaceuticals Business Overview

11.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction

11.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2019-2024)

11.5.5 Anacor Pharmaceuticals Recent Developments

11.6 Celgene

11.6.1 Celgene Company Details

11.6.2 Celgene Business Overview

11.6.3 Celgene Skin Disease Treatment Introduction

11.6.4 Celgene Revenue in Skin Disease Treatment Business (2019-2024)

11.6.5 Celgene Recent Developments

11.7 Basilea Pharmaceutica

11.7.1 Basilea Pharmaceutica Company Details

11.7.2 Basilea Pharmaceutica Business Overview

11.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction

11.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2019-2024)

11.7.5 Basilea Pharmaceutica Recent Developments

11.8 Cipher Pharmaceuticals

11.8.1 Cipher Pharmaceuticals Company Details

11.8.2 Cipher Pharmaceuticals Business Overview

11.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction

11.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2019-2024)

11.8.5 Cipher Pharmaceuticals Recent Developments

11.9 Agenus

11.9.1 Agenus Company Details

11.9.2 Agenus Business Overview

11.9.3 Agenus Skin Disease Treatment Introduction

11.9.4 Agenus Revenue in Skin Disease Treatment Business (2019-2024)

11.9.5 Agenus Recent Developments

11.10 Astion Pharma A/S

11.10.1 Astion Pharma A/S Company Details

11.10.2 Astion Pharma A/S Business Overview

11.10.3 Astion Pharma A/S Skin Disease Treatment Introduction

11.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2019-2024)

11.10.5 Astion Pharma A/S Recent Developments

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Details

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction

11.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2019-2024)

11.11.5 Bristol-Myers Squibb Recent Developments

11.12 Almirall S.A.

11.12.1 Almirall S.A. Company Details

11.12.2 Almirall S.A. Business Overview

11.12.3 Almirall S.A. Skin Disease Treatment Introduction

11.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2019-2024)

11.12.5 Almirall S.A. Recent Developments

11.13 Galderma

11.13.1 Galderma Company Details

11.13.2 Galderma Business Overview

11.13.3 Galderma Skin Disease Treatment Introduction

11.13.4 Galderma Revenue in Skin Disease Treatment Business (2019-2024)

11.13.5 Galderma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Anacor Pharmaceuticals

Celgene

Basilea Pharmaceutica

Cipher Pharmaceuticals

List of Tables

Table 1. Global Skin Disease Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Medicated Creams and Ointments

Table 3. Key Players of Antibiotics

Table 4. Key Players of Vitamins and Steroids

Table 5. Key Players of Antihistamines

Table 6. Key Players of Laser Therapy

Table 7. Key Players of Antifungals

Table 8. Key Players of Others

Table 9. Global Skin Disease Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 10. Global Skin Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Skin Disease Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Skin Disease Treatment Market Share by Region (2019-2024)

Table 13. Global Skin Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Skin Disease Treatment Market Share by Region (2025-2030)

Table 15. Skin Disease Treatment Market Trends

Table 16. Skin Disease Treatment Market Drivers

Table 17. Skin Disease Treatment Market Challenges

Table 18. Skin Disease Treatment Market Restraints

Table 19. Global Skin Disease Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Skin Disease Treatment Revenue Share by Players (2019-2024)

Table 21. Global Top Skin Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Disease Treatment as of 2023)

Table 22. Global Skin Disease Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 23. Global 5 Largest Players Market Share by Skin Disease Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 24. Global Key Players of Skin Disease Treatment, Headquarters and Area Served

Table 25. Global Key Players of Skin Disease Treatment, Product and Application

Table 26. Global Key Players of Skin Disease Treatment, Product and Application

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Skin Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Skin Disease Treatment Revenue Market Share by Type (2019-2024)

Table 30. Global Skin Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Skin Disease Treatment Revenue Market Share by Type (2025-2030)

Table 32. Global Skin Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Skin Disease Treatment Revenue Share by Application (2019-2024)

Table 34. Global Skin Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Skin Disease Treatment Revenue Share by Application (2025-2030)

Table 36. North America Skin Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 37. North America Skin Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 38. North America Skin Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 39. North America Skin Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 40. North America Skin Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. North America Skin Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. North America Skin Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Europe Skin Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 44. Europe Skin Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 45. Europe Skin Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 46. Europe Skin Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 47. Europe Skin Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Europe Skin Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 49. Europe Skin Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 50. China Skin Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 51. China Skin Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 52. China Skin Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 53. China Skin Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Skin Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 55. Asia Skin Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 56. Asia Skin Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 57. Asia Skin Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 58. Asia Skin Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 59. Asia Skin Disease Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 60. Asia Skin Disease Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Skin Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 66. Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 67. Middle East, Africa, and Latin America Skin Disease Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 68. APEIRON Biologics AG Company Details

Table 69. APEIRON Biologics AG Business Overview

Table 70. APEIRON Biologics AG Skin Disease Treatment Product

Table 71. APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 72. APEIRON Biologics AG Recent Developments

Table 73. HanAll BioPharma Company Details

Table 74. HanAll BioPharma Business Overview

Table 75. HanAll BioPharma Skin Disease Treatment Product

Table 76. HanAll BioPharma Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 77. HanAll BioPharma Recent Developments

Table 78. GlaxoSmithKline plc. Company Details

Table 79. GlaxoSmithKline plc. Business Overview

Table 80. GlaxoSmithKline plc. Skin Disease Treatment Product

Table 81. GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 82. GlaxoSmithKline plc. Recent Developments

Table 83. Allergen, Plc. Company Details

Table 84. Allergen, Plc. Business Overview

Table 85. Allergen, Plc. Skin Disease Treatment Product

Table 86. Allergen, Plc. Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 87. Allergen, Plc. Recent Developments

Table 88. Anacor Pharmaceuticals Company Details

Table 89. Anacor Pharmaceuticals Business Overview

Table 90. Anacor Pharmaceuticals Skin Disease Treatment Product

Table 91. Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 92. Anacor Pharmaceuticals Recent Developments

Table 93. Celgene Company Details

Table 94. Celgene Business Overview

Table 95. Celgene Skin Disease Treatment Product

Table 96. Celgene Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 97. Celgene Recent Developments

Table 98. Basilea Pharmaceutica Company Details

Table 99. Basilea Pharmaceutica Business Overview

Table 100. Basilea Pharmaceutica Skin Disease Treatment Product

Table 101. Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 102. Basilea Pharmaceutica Recent Developments

Table 103. Cipher Pharmaceuticals Company Details

Table 104. Cipher Pharmaceuticals Business Overview

Table 105. Cipher Pharmaceuticals Skin Disease Treatment Product

Table 106. Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 107. Cipher Pharmaceuticals Recent Developments

Table 108. Agenus Company Details

Table 109. Agenus Business Overview

Table 110. Agenus Skin Disease Treatment Product

Table 111. Agenus Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 112. Agenus Recent Developments

Table 113. Astion Pharma A/S Company Details

Table 114. Astion Pharma A/S Business Overview

Table 115. Astion Pharma A/S Skin Disease Treatment Product

Table 116. Astion Pharma A/S Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 117. Astion Pharma A/S Recent Developments

Table 118. Bristol-Myers Squibb Company Details

Table 119. Bristol-Myers Squibb Business Overview

Table 120. Bristol-Myers Squibb Skin Disease Treatment Product

Table 121. Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 122. Bristol-Myers Squibb Recent Developments

Table 123. Almirall S.A. Company Details

Table 124. Almirall S.A. Business Overview

Table 125. Almirall S.A. Skin Disease Treatment Product

Table 126. Almirall S.A. Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 127. Almirall S.A. Recent Developments

Table 128. Galderma Company Details

Table 129. Galderma Business Overview

Table 130. Galderma Skin Disease Treatment Product

Table 131. Galderma Revenue in Skin Disease Treatment Business (2019-2024) & (US$ Million)

Table 132. Galderma Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Skin Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Skin Disease Treatment Market Share by Type: 2023 VS 2030

Figure 3. Medicated Creams and Ointments Features

Figure 4. Antibiotics Features

Figure 5. Vitamins and Steroids Features

Figure 6. Antihistamines Features

Figure 7. Laser Therapy Features

Figure 8. Antifungals Features

Figure 9. Others Features

Figure 10. Global Skin Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Skin Disease Treatment Market Share by Application: 2023 VS 2030

Figure 12. Dermatology Clinics Case Studies

Figure 13. Skincare Clinics Case Studies

Figure 14. Hospitals Case Studies

Figure 15. Aesthetic Centers Case Studies

Figure 16. Others Case Studies

Figure 17. Skin Disease Treatment Report Years Considered

Figure 18. Global Skin Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Skin Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Skin Disease Treatment Market Share by Region: 2023 VS 2030

Figure 21. Global Skin Disease Treatment Market Share by Players in 2023

Figure 22. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Disease Treatment as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Skin Disease Treatment Revenue in 2023

Figure 24. North America Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Skin Disease Treatment Market Share by Type (2019-2030)

Figure 26. North America Skin Disease Treatment Market Share by Application (2019-2030)

Figure 27. North America Skin Disease Treatment Market Share by Country (2019-2030)

Figure 28. United States Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Canada Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Skin Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 31. Europe Skin Disease Treatment Market Share by Type (2019-2030)

Figure 32. Europe Skin Disease Treatment Market Share by Application (2019-2030)

Figure 33. Europe Skin Disease Treatment Market Share by Country (2019-2030)

Figure 34. Germany Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. France Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. U.K. Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Italy Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Russia Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Nordic Countries Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. China Skin Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 41. China Skin Disease Treatment Market Share by Type (2019-2030)

Figure 42. China Skin Disease Treatment Market Share by Application (2019-2030)

Figure 43. Asia Skin Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 44. Asia Skin Disease Treatment Market Share by Type (2019-2030)

Figure 45. Asia Skin Disease Treatment Market Share by Application (2019-2030)

Figure 46. Asia Skin Disease Treatment Market Share by Region (2019-2030)

Figure 47. Japan Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. South Korea Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. China Taiwan Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Southeast Asia Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. India Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Australia Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Skin Disease Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 54. Middle East, Africa, and Latin America Skin Disease Treatment Market Share by Type (2019-2030)

Figure 55. Middle East, Africa, and Latin America Skin Disease Treatment Market Share by Application (2019-2030)

Figure 56. Middle East, Africa, and Latin America Skin Disease Treatment Market Share by Country (2019-2030)

Figure 57. Brazil Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Mexico Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Turkey Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Saudi Arabia Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Israel Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. GCC Countries Skin Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 63. APEIRON Biologics AG Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 64. HanAll BioPharma Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 65. GlaxoSmithKline plc. Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 66. Allergen, Plc. Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 67. Anacor Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 68. Celgene Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 69. Basilea Pharmaceutica Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 70. Cipher Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 71. Agenus Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 72. Astion Pharma A/S Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 73. Bristol-Myers Squibb Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 74. Almirall S.A. Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 75. Galderma Revenue Growth Rate in Skin Disease Treatment Business (2019-2024)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions